Matthew Kent will be a speaker on this program hosted by the American Bar Association. Rising prices for prescription drugs have spawned a raft of antitrust cases and regulatory inquiries on both sides of the Atlantic. This panel will consider the use of antitrust litigation and legislative efforts in the U.S. and Europe to address perceived market failures in the pharmaceutical arena.
For more information, click here.